The importance of valency in enhancing the import and cell routing potential of protein transduction domain-containing molecules

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 3, 2006, Pages 355-363

  Sung, Michael ^a   Poon, Gregory M K ^a   Gariépy, Jean ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; LIPOSOME; NANOPARTICLE; PEPTIDE DERIVATIVE; PLASMID DNA; PROTEIN P53; TETRAMER;

AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS; CELL TYPE; CELLULAR DISTRIBUTION; ENDOSOME; MACROMOLECULE; MOLECULAR WEIGHT; NUCLEAR LOCALIZATION SIGNAL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; NUCLEAR LOCALIZATION SIGNALS; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53; VEHICLES;

EID: 33646517964     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.11.016     Document Type: Article

References (114)

1. Kiessling L.L., Gestwicki J.E., and Strong L.E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr. Opin. Chem. Biol. 4 (2000) 696-703
2. Lee Y.C., Townsend R.R., Hardy M.R., Lonngren J., Arnarp J., Haraldsson M., and Lonn H. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258 (1983) 199-202
3. Mammen M., Choi S.-K., and Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed. 37 (1998) 2754-2794
4. Page M.I., and Jencks W.P. Entropic contributions to rate accelerations in enzymic and intramolecular reactions and the chelate effect. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 1678-1683
5. Schwarzenbach G. Der Chelateffekt. Helv. Chim. Acta 35 (1952) 2344-2363
6. Crothers D.M., and Metzger H. The influence of polyvalency on the binding properties of antibodies. Immunochemistry 9 (1972) 341-357
7. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5879-5883
8. Huhalov A., and Chester K.A. Engineered single chain antibody fragments for radioimmunotherapy. Q. J. Nucl. Med. Mol. Imaging 48 (2004) 279-288
9. Borsi L., Balza E., Bestagno M., Castellani P., Carnemolla B., Biro A., Leprini A., Sepulveda J., Burrone O., Neri D., and Zardi L. Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int. J. Cancer 102 (2002) 75-85
10. Goel A., Colcher D., Baranowska-Kortylewicz J., Augustine S., Booth B.J., Pavlinkova G., and Batra S.K. Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application. Cancer Res. 60 (2000) 6964-6971
11. Hu S., Shively L., Raubitschek A., Sherman M., Williams L.E., Wong J.Y., Shively J.E., and Wu A.M. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 56 (1996) 3055-3061
12. Santimaria M., Moscatelli G., Viale G.L., Giovannoni L., Neri G., Viti F., Leprini A., Borsi L., Castellani P., Zardi L., Neri D., and Riva P. Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer. Clin. Cancer Res. 9 (2003) 571-579
13. Willuda J., Kubetzko S., Waibel R., Schubiger P.A., Zangemeister-Wittke U., and Pluckthun A. Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J. Biol. Chem. 276 (2001) 14385-14392
14. Kitov P.I., and Bundle D.R. On the nature of the multivalency effect: a thermodynamic model. J. Am. Chem. Soc. 125 (2003) 16271-16284
15. Kollen W.J., Schembri F.M., Gerwig G.J., Vliegenthart J.F., Glick M.C., and Scanlin T.F. Enhanced efficiency of lactosylated poly-l-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 20 (1999) 1081-1086
16. Midoux P., Mendes C., Legrand A., Raimond J., Mayer R., Monsigny M., and Roche A.C. Specific gene transfer mediated by lactosylated poly-l-lysine into hepatoma cells. Nucleic Acids Res. 21 (1993) 871-878
17. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., and Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56 (2000) 318-325
18. Ryser H.J., and Hancock R. Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150 (1965) 501-503
19. Ryser H.J. Uptake of protein by mammalian cells: an underdeveloped area. The penetration of foreign proteins into mammalian cells can be measured and their functions explored. Science 159 (1968) 390-396
20. Ryser H.J. A membrane effect of basic polymers dependent on molecular size. Nature 215 (1967) 934-936
21. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
22. Phelan A., Elliott G., and O'Hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16 (1998) 440-443
23. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
24. Bisland S.K., Singh D., and Gariepy J. Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjug. Chem. 10 (1999) 982-992
25. Gariepy J., and Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol. 19 (2001) 21-28
26. Kawamura K.S., Su R.C., Nguyen L.T., Elford A.R., Ohashi P.S., and Gariepy J. In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles. J. Immunol. 168 (2002) 5709-5715
27. Singh D., Bisland S.K., Kawamura K., and Gariepy J. Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells. Bioconjug. Chem. 10 (1999) 745-754
28. Singh D., Kiarash R., Kawamura K., LaCasse E.C., and Gariepy J. Penetration and intracellular routing of nucleus-directed peptide-based shuttles (loligomers) in eukaryotic cells. Biochemistry 37 (1998) 5798-5809
29. Zhao M., Kircher M.F., Josephson L., and Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 13 (2002) 840-844
30. Barka T., Gresik E.W., and van Der Noen H. Transduction of TAT-HA-beta-galactosidase fusion protein into salivary gland-derived cells and organ cultures of the developing gland, and into rat submandibular gland in vivo. J. Histochem. Cytochem. 48 (2000) 1453-1460
31. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 664-668
32. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
33. Eum W.S., Choung I.S., Kim A.Y., Lee Y.J., Kang J.H., Park J., Lee K.S., Kwon H.Y., and Choi S.Y. Transduction efficacy of Tat-Cu,Zn-superoxide dismutase is enhanced by copper ion recovery of the fusion protein. Mol. Cells 13 (2002) 334-340
34. Kwon H.Y., Eum W.S., Jang H.W., Kang J.H., Ryu J., Ryong Lee B., Jin L.H., Park J., and Choi S.Y. Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett. 485 (2000) 163-167
35. Park J., Ryu J., Jin L.H., Bahn J.H., Kim J.A., Yoon C.S., Kim D.W., Han K.H., Eum W.S., Kwon H.Y., Kang T.C., Won M.H., Kang J.H., Cho S.W., and Choi S.Y. 9-polylysine protein transduction domain: enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol. Cells 13 (2002) 202-208
36. Harada H., Hiraoka M., and Kizaka-Kondoh S. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res. 62 (2002) 2013-2018
37. Tasciotti E., Zoppe M., and Giacca M. Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat. Cancer Gene Ther. 10 (2003) 64-74
38. Dilber M.S., Phelan A., Aints A., Mohamed A.J., Elliott G., Smith C.I., and O'Hare P. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6 (1999) 12-21
39. Liu C.S., Kong B., Xia H.H., Ellem K.A., and Wei M.Q. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J. Gene Med. 3 (2001) 145-152
40. Kim D.T., Mitchell D.J., Brockstedt D.G., Fong L., Nolan G.P., Fathman C.G., Engleman E.G., and Rothbard J.B. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J. Immunol. 159 (1997) 1666-1668
41. Moy P., Daikh Y., Pepinsky B., Thomas D., Fawell S., and Barsoum J. Tat-mediated protein delivery can facilitate MHC class I presentation of antigens. Mol. Biotechnol. 6 (1996) 105-113
42. Shibagaki N., and Udey M.C. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J. Immunol. 168 (2002) 2393-2401
43. Matsushita M., Noguchi H., Lu Y.F., Tomizawa K., Michiue H., Li S.T., Hirose K., Bonner-Weir S., and Matsui H. Photo-acceleration of protein release from endosome in the protein transduction system. FEBS Lett. 572 (2004) 221-226
44. Michiue H., Tomizawa K., Wei F.Y., Matsushita M., Lu Y.F., Ichikawa T., Tamiya T., Date I., and Matsui H. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J. Biol. Chem. 280 (2005) 8285-8289
45. Albarran B., To R., and Stayton P.S. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Eng. Des. Sel. 18 (2005) 147-152
46. Kilk K., Magzoub M., Pooga M., Eriksson L.E., Langel U., and Graslund A. Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide. Bioconjug. Chem. 12 (2001) 911-916
47. Mi Z., Mai J., Lu X., and Robbins P.D. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2 (2000) 339-347
48. Jin L.H., Bahn J.H., Eum W.S., Kwon H.Y., Jang S.H., Han K.H., Kang T.C., Won M.H., Kang J.H., Cho S.W., Park J., and Choi S.Y. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic. Biol. Med. 31 (2001) 1509-1519
49. Watanabe N., Iwamoto T., Bowen K.D., Dickinson D.A., Torres M., and Forman H.J. Bio-effectiveness of Tat-catalase conjugate: a potential tool for the identification of H2O2-dependent cellular signal transduction pathways. Biochem. Biophys. Res. Commun. 303 (2003) 287-293
50. Orii K.O., Grubb J.H., Vogler C., Levy B., Tan Y., Markova K., Davidson B.L., Mao Q., Orii T., Kondo N., and Sly W.S. Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol. Ther. 12 (2005) 345-352
51. Yoon H.Y., Lee S.H., Cho S.W., Lee J.E., Yoon C.S., Park J., Kim T.U., and Choi S.Y. TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem. Int. 41 (2002) 37-42
52. Sheldon K., Liu D., Ferguson J., and Gariepy J. Loligomers: design of de novo peptide-based intracellular vehicles. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2056-2060
53. Ezhevsky S.A., Nagahara H., Vocero-Akbani A.M., Gius D.R., Wei M.C., and Dowdy S.F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10699-10704
54. Lea N.C., Orr S.J., Stoeber K., Williams G.H., Lam E.W., Ibrahim M.A., Mufti G.J., and Thomas N.S. Commitment point during G0→G1 that controls entry into the cell cycle. Mol. Cell. Biol. 23 (2003) 2351-2361
55. Kato D., Miyazawa K., Ruas M., Starborg M., Wada I., Oka T., Sakai T., Peters G., and Hara E. Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts. FEBS Lett. 427 (1998) 203-208
56. Fretz M.M., Koning G.A., Mastrobattista E., Jiskoot W., and Storm G. OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim. Biophys. Acta 1665 (2004) 48-56
57. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8786-8791
58. Console S., Marty C., Garcia-Echeverria C., Schwendener R., and Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278 (2003) 35109-35114
59. Tseng Y.L., Liu J.J., and Hong R.L. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol. Pharmacol. 62 (2002) 864-872
60. Moriguchi R., Kogure K., Akita H., Futaki S., Miyagishi M., Taira K., and Harashima H. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm. 301 (2005) 277-285
61. Bhorade R., Weissleder R., Nakakoshi T., Moore A., and Tung C.H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug. Chem. 11 (2000) 301-305
62. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., and Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18 (2000) 410-414
63. Wunderbaldinger P., Josephson L., and Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. 13 (2002) 264-268
64. Hellgren I., Gorman J., and Sylven C. Factors controlling the efficiency of Tat-mediated plasmid DNA transfer. J. Drug Target. 12 (2004) 39-47
65. Nakanishi M., Eguchi A., Akuta T., Nagoshi E., Fujita S., Okabe J., Senda T., and Hasegawa M. Basic peptides as functional components of non-viral gene transfer vehicles. Curr. Protein Pept. Sci. 4 (2003) 141-150
66. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., and Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278 (2003) 11411-11418
67. Ou J., Geiger T., Ou Z., Ackerman A.W., Oldham K.T., and Pritchard Jr. K.A. AP-4F, antennapedia peptide linked to an amphipathic alpha helical peptide, increases the efficiency of lipofectamine-mediated gene transfection in endothelial cells. Biochem. Biophys. Res. Commun. 305 (2003) 605-610
68. Sarkar T., Conwell C.C., Harvey L.C., Santai C.T., and Hud N.V. Condensation of oligonucleotides assembled into nicked and gapped duplexes: potential structures for oligonucleotide delivery. Nucleic Acids Res. 33 (2005) 143-151
69. Sosnowski B.A., Gonzalez A.M., Chandler L.A., Buechler Y.J., Pierce G.F., and Baird A. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J. Biol. Chem. 271 (1996) 33647-33653
70. Wu C.H., Wilson J.M., and Wu G.Y. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J. Biol. Chem. 264 (1989) 16985-16987
71. Sparrow J.T., Edwards V.V., Tung C., Logan M.J., Wadhwa M.S., Duguid J., and Smith L.C. Synthetic peptide-based DNA complexes for nonviral gene delivery. Adv. Drug Deliv. Rev. 30 (1998) 115-131
72. Sandgren S., Cheng F., and Belting M. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277 (2002) 38877-38883
73. Wang J., Dai H., Yousaf N., Moussaif M., Deng Y., Boufelliga A., Swamy O.R., Leone M.E., and Riedel H. Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis. Mol. Cell. Biol. 19 (1999) 6217-6228
74. Chen M., Won D.J., Krajewski S., and Gottlieb R.A. Calpain and mitochondria in ischemia/reperfusion injury. J. Biol. Chem. 277 (2002) 29181-29186
75. Asoh S., Ohsawa I., Mori T., Katsura K., Hiraide T., Katayama Y., Kimura M., Ozaki D., Yamagata K., and Ohta S. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17107-17112
76. Li H., Yao Z., Degenhardt B., Teper G., and Papadopoulos V. Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1267-1272
77. Tanaka Y., Dowdy S.F., Linehan D.C., Eberlein T.J., and Goedegebuure P.S. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells. J. Immunol. 170 (2003) 1291-1298
78. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., and Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
79. Linding R., Schymkowitz J., Rousseau F., Diella F., and Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J. Mol. Biol. 342 (2004) 345-353
80. Lepock J.R., Arnold L.D., Torrie B.H., Andrews B., and Kruuv J. Structural analyses of various Cu2+, Zn2+-superoxide dismutases by differential scanning calorimetry and Raman spectroscopy. Arch. Biochem. Biophys. 241 (1985) 243-251
81. Oneda H., and Inouye K. Effect of nitration on the activity of bovine erythrocyte Cu,Zn-superoxide dismutase (BESOD) and a kinetic analysis of its dimerization-dissociation reaction as examined by subunit exchange between the native and nitrated BESODs. J. Biochem. (Tokyo) 134 (2003) 683-690
82. Roe J.A., Butler A., Scholler D.M., Valentine J.S., Marky L., and Breslauer K.J. Differential scanning calorimetry of Cu,Zn-superoxide dismutase, the apoprotein, and its zinc-substituted derivatives. Biochemistry 27 (1988) 950-958
83. Edwards R.A., and Huber R.E. Surface denaturation of proteins: the thermal inactivation of beta-galactosidase (Escherichia coli) on wall-liquid surfaces. Biochem. Cell. Biol. 70 (1992) 63-69
84. Edwards R.A., Jacobson A.L., and Huber R.E. Thermal denaturation of beta-galactosidase and of two site-specific mutants. Biochemistry 29 (1990) 11001-11008
85. Tomino S., and Meisler M. Biochemical and immunological studies of purified mouse beta-galactosidase. J. Biol. Chem. 250 (1975) 7752-7758
86. Banci L., Benedetto M., Bertini I., Del Conte R., Piccioli M., and Viezzoli M.S. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?. Biochemistry 37 (1998) 11780-11791
87. Bertini I., Piccioli M., Viezzoli M.S., Chiu C.Y., and Mullenbach G.T. A spectroscopic characterization of a monomeric analog of copper, zinc superoxide dismutase. Eur. Biophys. J. 23 (1994) 167-176
88. Gonzalez M., Bagatolli L.A., Echabe I., Arrondo J.L., Argarana C.E., Cantor C.R., and Fidelio G.D. Interaction of biotin with streptavidin. Thermostability and conformational changes upon binding. J. Biol. Chem. 272 (1997) 11288-11294
89. Waner M.J., Navrotskaya I., Bain A., Oldham E.D., and Mascotti D.P. Thermal and sodium dodecylsulfate induced transitions of streptavidin. Biophys. J. 87 (2004) 2701-2713
90. Niemeyer C.M., Adler M., Pignataro B., Lenhert S., Gao S., Chi L., Fuchs H., and Blohm D. Self-assembly of DNA-streptavidin nanostructures and their use as reagents in immuno-PCR. Nucleic Acids Res. 27 (1999) 4553-4561
91. Torchilin V.P. TAT peptide-modified liposomes for intracellular delivery of drugs and DNA. Cell. Mol. Biol. Lett. 7 (2002) 265-267
92. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1972-1977
93. Koch A.M., Reynolds F., Merkle H.P., Weissleder R., and Josephson L. Transport of surface-modified nanoparticles through cell monolayers. Chembiochemistry 6 (2005) 337-345
94. Kircher M.F., Allport J.R., Graves E.E., Love V., Josephson L., Lichtman A.H., and Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63 (2003) 6838-6846
95. Goldfarb D.S., Gariepy J., Schoolnik G., and Kornberg R.D. Synthetic peptides as nuclear localization signals. Nature 322 (1986) 641-644
96. Dingwall C., Sharnick S.V., and Laskey R.A. A polypeptide domain that specifies migration of nucleoplasmin into the nucleus. Cell 30 (1982) 449-458
97. Dworetzky S.I., Lanford R.E., and Feldherr C.M. The effects of variations in the number and sequence of targeting signals on nuclear uptake. J. Cell Biol. 107 (1988) 1279-1287
98. Akhlynina T.V., Jans D.A., Rosenkranz A.A., Statsyuk N.V., Balashova I.Y., Toth G., Pavo I., Rubin A.B., and Sobolev A.S. Nuclear targeting of chlorin e6 enhances its photosensitizing activity. J. Biol. Chem. 272 (1997) 20328-20331
99. Litowski J.R., and Hodges R.S. Designing heterodimeric two-stranded alpha-helical coiled-coils: the effect of chain length on protein folding, stability and specificity. J. Pept. Res. 58 (2001) 477-492
100. Johnson C.R., Morin P.E., Arrowsmith C.H., and Freire E. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. Biochemistry 34 (1995) 5309-5316
101. Lee W., Harvey T.S., Yin Y., Yau P., Litchfield D., and Arrowsmith C.H. Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1 (1994) 877-890
102. Davison T.S., Yin P., Nie E., Kay C., and Arrowsmith C.H. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome. Oncogene 17 (1998) 651-656
103. K.S. Kawamura, M. Sung, E. Bolewska-Pedyczak, J. Gariépy, Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells, Biochemistry (in press).
104. Li W., Nicol F., and Szoka Jr. F.C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56 (2004) 967-985
105. Bello Roufai M., and Midoux P. Histidylated polylysine as DNA vector: elevation of the imidazole protonation and reduced cellular uptake without change in the polyfection efficiency of serum stabilized negative polyplexes. Bioconjug. Chem. 12 (2001) 92-99
106. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297-7301
107. Putnam D., Gentry C.A., Pack D.W., and Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1200-1205
108. Singh R.S., Goncalves C., Sandrin P., Pichon C., Midoux P., and Chaudhuri A. On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation. Chem. Biol. 11 (2004) 713-723
109. Schally A.V., and Nagy A. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin. Life Sci. 72 (2003) 2305-2320
110. Schally A.V., and Nagy A. Chemotherapy targeted to cancers through tumoral hormone receptors. Trends Endocrinol. Metab. 15 (2004) 300-310
111. Schally A.V., Szepeshazi K., Nagy A., Comaru-Schally A.M., and Halmos G. New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs. Cell. Mol. Life Sci. 61 (2004) 1042-1068
112. Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
113. Essler M., and Ruoslahti E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2252-2257
114. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkila P., Kantor C., Gahmberg C.G., Salo T., Konttinen Y.T., Sorsa T., Ruoslahti E., and Pasqualini R. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17 (1999) 768-774